Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 813.96x is 20% below its estimated 1-year average of 1017.86x, near the low end of its estimated 1-year range (813.96x–1190.07x).
As of 2026-10-06T18:51:49.705Z.
Calculation as of: 2026-10-06T18:51:49.705Z.
Quote observation: 2026-10-06T18:50:07.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 88e906b5462319013e69f4ee379284aaffb96e00f9acc248208650345dd3e90c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
813.96x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.33x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+18698.15%
vs the sector median at left
Market Cap
$6.52B
EV/Sales Ratio
2.89x
TTM Avg
3.61x
3Y Avg
4.31x
5Y Avg
3.99x
Market Cap
$6.51B
EV/Sales Ratio
2.94x
TTM Avg
2.38x
3Y Avg
1.99x
5Y Avg
1.79x
Market Cap
$6.51B
EV/Sales Ratio
4.20x
TTM Avg
3.66x
3Y Avg
3.86x
5Y Avg
4.88x
Market Cap
$6.22B
EV/Sales Ratio
25.65x
TTM Avg
33.87x
3Y Avg
32.23x
5Y Avg
85.35x
Market Cap
$5.95B
EV/Sales Ratio
20.89x
TTM Avg
19.21x
3Y Avg
14.50x
5Y Avg
11.12x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | $6.57B | 813.96x | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.52B | 2.89x | 3.61x | 4.31x | 3.99x |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.51B | 2.94x | 2.38x | 1.99x | 1.79x |
| Lantheus Holdings, Inc. (LNTH)vs › | $6.51B | 4.20x | 3.66x | 3.86x | 4.88x |
| Chemed Corporation (CHE)vs › | $6.66B | 2.68x | 2.53x | 3.22x | 3.39x |
| Rhythm Pharmaceuticals, Inc. (RYTM)vs › | $6.22B | 25.65x | 33.87x | 32.23x | 85.35x |
| Alkermes plc (ALKS)vs › | $7.02B | 4.85x | 4.05x | 3.30x | 3.53x |
| Kodiak Sciences Inc. (KOD)vs › | $5.90B | N/A | N/A | N/A | N/A |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.95B | 20.89x | 19.21x | 14.50x | 11.12x |
| GRAIL Inc. (GRAL)vs › | $5.93B | 36.13x | 19.59x | 14.79x | 14.79x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 850.82x |
| 2026-10-02 | 861.54x |
| 2026-10-01 | 862.41x |
| 2026-09-30 | 866.18x |
| 2026-09-29 | 856.91x |
| 2026-09-28 | 857.78x |
| 2026-09-25 | 852.27x |
| 2026-09-24 | 872.55x |
| 2026-09-23 | 888.19x |
| 2026-09-22 | 967.86x |
| 2026-09-21 | 964.68x |
| 2026-09-18 | 958.01x |
| 2026-09-17 | 978.29x |
| 2026-09-16 | 941.50x |
| 2026-09-15 | 949.32x |
| 2026-09-14 | 978.58x |
| 2026-09-11 | 969.89x |
| 2026-09-10 | 991.33x |
| 2026-09-09 | 1010.16x |
| 2026-09-08 | 1033.92x |
| 2026-09-04 | 1024.65x |
| 2026-09-03 | 1020.88x |
| 2026-09-02 | 1031.60x |
| 2026-09-01 | 1043.48x |
| 2026-08-31 | 1070.13x |
| 2026-08-28 | 1081.14x |
| 2026-08-27 | 1157.04x |
| 2026-08-26 | 1159.07x |
| 2026-08-25 | 1147.77x |
| 2026-08-24 | 1142.55x |
| 2026-08-21 | 1172.97x |
| 2026-08-20 | 1172.39x |
| 2026-08-19 | 1190.07x |
| 2026-08-18 | 1170.95x |
| 2026-08-17 | 1153.85x |
| 2026-08-14 | 1099.10x |
| 2026-08-13 | 1099.10x |
| 2026-08-12 | 1121.70x |
| 2026-08-11 | 1073.32x |
| 2026-08-10 | 1043.19x |
| 2026-08-07 | 1044.92x |
